The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-hydroxynaphthalen-1-yl)-2-oxo-2H-naphtho[1,8-bc]thiophene-7-sulfonamide ID: ALA3360268
PubChem CID: 118724179
Max Phase: Preclinical
Molecular Formula: C21H13NO4S2
Molecular Weight: 407.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Sc2cc(S(=O)(=O)Nc3ccc(O)c4ccccc34)cc3cccc1c23
Standard InChI: InChI=1S/C21H13NO4S2/c23-18-9-8-17(14-5-1-2-6-15(14)18)22-28(25,26)13-10-12-4-3-7-16-20(12)19(11-13)27-21(16)24/h1-11,22-23H
Standard InChI Key: ZZAUVGINMLVAHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
3.5783 -3.4050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9910 -4.1148 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3994 -3.4025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2853 -4.5276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7007 -4.5276 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4084 -4.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5754 -4.1198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8701 -4.5318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2919 -5.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8225 -3.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1098 -2.8976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4055 -3.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8220 -4.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1162 -4.5302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1160 -5.3427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8210 -5.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5275 -5.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5242 -4.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5296 -2.8965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5895 -5.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1788 -6.5804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8945 -6.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5963 -6.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1738 -5.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8839 -5.3510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8963 -4.4636 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.5635 -5.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2431 -5.3844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 1 0
4 7 1 0
7 8 2 0
8 25 1 0
20 9 1 0
9 4 2 0
6 14 2 0
13 10 2 0
10 11 1 0
11 12 2 0
12 6 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
10 19 1 0
20 25 2 0
24 21 2 0
21 22 1 0
22 23 2 0
23 20 1 0
24 25 1 0
26 27 1 0
27 24 1 0
8 26 1 0
27 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.47Molecular Weight (Monoisotopic): 407.0286AlogP: 4.75#Rotatable Bonds: 3Polar Surface Area: 83.47Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.56CX Basic pKa: ┄CX LogP: 4.10CX LogD: 3.90Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -0.81
References 1. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ.. (2014) Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads., 57 (19): [PMID:25244355 ] [10.1021/jm500863j ]